Literature DB >> 9531799

[Endoscopically controlled erbium YAG laser goniotomy. Initial preclinical trials].

J Funk1, G Schlunck.   

Abstract

INTRODUCTION: Endoscopic erbium-YAG laser treatment is a new approach in glaucoma surgery. In contrast to conventional laser systems, the photoablative erbium-YAG laser allows microperforations of the trabecular meshwork without thermal side effects. We report our first preclinical trials using this new system.
METHOD: We used the Endognost system (Schwind Co.). The device combines an endoscope and illumination fiber (0.5 mm diameter), laser fiber (0.5 mm) and a irrigation tube in one probe with a 1.1 mm external diameter. The Endognost system was tested in porcine and enucleated human eyes. All eyes were examined histologically.
RESULTS: The endoscopic view into the anterior chamber allows for precise allocation of the laser pulses. Using a single pulse mode with 10 mJ a micropuncture of the trabecular meshwork can be achieved without damaging the adjacent tissue. Using multiple pulses or higher energy levels leads to damage of the posterior wall of Schlemm's canal and to thermal side effects.
CONCLUSIONS: Endoscope guided erbium-YAG laser effects on trabecular tissue are comparable to those produced by a 308 nm excimer laser. Therefore, a similar reduction in intraocular pressure can be expected.

Entities:  

Mesh:

Year:  1998        PMID: 9531799     DOI: 10.1007/s003470050232

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  3 in total

1.  [Combined cataract and glaucoma surgery. Trabeculectomy vs Erb:YAG goniotomy].

Authors:  S Beuerle; H Philippin; J Funk
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

Review 2.  [Excimer laser trabeculotomy: minimally invasive glaucoma surgery].

Authors:  S Herdener; M Pache
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

3.  Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy.

Authors:  Heiko Philippin; Sonja Wilmsmeyer; Nicolas Feltgen; Thomas Ness; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.